Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.
about
Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancerIntegration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel.Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates.Predictive value of phosphorylated mammalian target of rapamycin for disease-free survival in breast cancer patients receiving neoadjuvant chemotherapy.Presurgical therapy in metastatic renal cell carcinoma.Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patientsSerum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer.pHLIP-mediated translocation of membrane-impermeable molecules into cells.Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastasesPredictors of complete pathological response after neoadjuvant systemic therapy for breast cancer.A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients.Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications
P2860
Q28706276-ADCD4110-F7AC-4C75-9359-0E276457E173Q31092479-3EF465FC-B70A-4B32-899C-1FD0D16D1E9BQ33893910-F904BE56-C348-4F82-B255-1A92B8D663E3Q34162875-0B1000B2-AF64-4B4D-8F95-EF1CD63DDACEQ34427536-02C804C7-9BDD-4885-966C-B501A6690A63Q36691815-5D450A8E-E9B8-4459-9852-82AC849FF3E2Q36763988-55811EFB-5271-46F0-B142-16588C8E8C88Q36787344-D4AA1537-7AF3-4972-B881-66A4C5E57F5BQ37340596-AFA3CF77-E8DD-4ADE-BDCC-FBE9889A13FAQ37352557-CC91ED81-568C-4E74-8FCC-93BC2155C3EEQ37584869-10CD63BF-A761-4102-A55D-EB6EA8222031Q38433690-A01F15F3-3DF6-44DD-8A4A-B823EA5E37DEQ54303001-98F82A39-6F8B-4F53-9263-8FB4E973B833Q57741327-970333BA-95A1-4AA0-ACD9-202EDA3AD20D
P2860
Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Neoadjuvant systemic therapy f ...... iew of recent clinical trials.
@ast
Neoadjuvant systemic therapy f ...... iew of recent clinical trials.
@en
type
label
Neoadjuvant systemic therapy f ...... iew of recent clinical trials.
@ast
Neoadjuvant systemic therapy f ...... iew of recent clinical trials.
@en
prefLabel
Neoadjuvant systemic therapy f ...... iew of recent clinical trials.
@ast
Neoadjuvant systemic therapy f ...... iew of recent clinical trials.
@en
P2093
P2860
P1476
Neoadjuvant systemic therapy f ...... iew of recent clinical trials.
@en
P2093
Bryan T Hennessy
Emer O Hanrahan
Vicente Valero
P2860
P304
P356
10.1517/14656566.6.9.1477
P407
P577
2005-08-01T00:00:00Z